Nationwide Fund Advisors’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-8,872
| Closed | -$33K | – | 890 |
|
|
2017
Q3 | $33K | Hold |
8,872
| – | – | ﹤0.01% | 3078 |
|
|
2017
Q2 | $23K | Hold |
8,872
| – | – | ﹤0.01% | 3104 |
|
|
2017
Q1 | $23K | Hold |
8,872
| – | – | ﹤0.01% | 3076 |
|
|
2016
Q4 | $27K | Hold |
8,872
| – | – | ﹤0.01% | 3064 |
|
|
2016
Q3 | $24K | Hold |
8,872
| – | – | ﹤0.01% | 3111 |
|
|
2016
Q2 | $25K | Sell |
8,872
-21,311
| -71% | -$60.1K | ﹤0.01% | 3140 |
|
|
2016
Q1 | $91K | Hold |
30,183
| – | – | ﹤0.01% | 2861 |
|
|
2015
Q4 | $105K | Buy |
30,183
+1,296
| +4% | +$4.51K | ﹤0.01% | 2825 |
|
|
2015
Q3 | $109K | Hold |
28,887
| – | – | ﹤0.01% | 2864 |
|
|
2015
Q2 | $165K | Buy |
28,887
+20,015
| +226% | +$114K | ﹤0.01% | 2801 |
|
|
2015
Q1 | $52K | Hold |
8,872
| – | – | ﹤0.01% | 3091 |
|
|
2014
Q4 | $50K | Hold |
8,872
| – | – | ﹤0.01% | 3023 |
|
|
2014
Q3 | $36K | Hold |
8,872
| – | – | ﹤0.01% | 3127 |
|
|
2014
Q2 | $40K | Sell |
8,872
-19,897
| -69% | -$89.7K | ﹤0.01% | 3111 |
|
|
2014
Q1 | $136K | Buy |
28,769
+431
| +2% | +$2.04K | ﹤0.01% | 2644 |
|
|
2013
Q4 | $133K | Sell |
28,338
-6,266
| -18% | -$29.4K | ﹤0.01% | 2852 |
|
|
2013
Q3 | $138K | Buy |
34,604
+4,131
| +14% | +$16.5K | ﹤0.01% | 2841 |
|
|
2013
Q2 | $109K | Buy |
+30,473
| New | +$109K | ﹤0.01% | 2769 |
|